BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Pacific Standard Time
X-LIC-LOCATION:America/Los_Angeles
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:PST
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:PDT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2025 Annual Meeting by the American Academy of Neurology\n\nTi
 tle: Industry Theraepeutic Update from Novartis Pharmaceuticals: From dat
 a to experience: Early considerations for an established B-cell therapy f
 or RMS with long-term patient results\n\nAccess URL: https://www.aan.com/
 MSA/Public/Events/GetEventURL/18299\n\nLearn More About This Event: https
 ://www.aan.com/MSA/Public/Events/Details/18299
DTEND;TZID=Pacific Standard Time:20250407T124500
DTSTAMP:20260421T081329Z
DTSTART;TZID=Pacific Standard Time:20250407T114500
LOCATION:https://www.aan.com/MSA/Public/Events/GetEventURL/18299
SEQUENCE:0
SUMMARY:AAN: Industry Theraepeutic Update from Novartis Pharmaceuticals: F
 rom data to experience: Early considerations for an established B-cell th
 erapy for RMS with long-term patient results
UID:d2bf439e-245c-43b1-97f9-5be04085a0a0
END:VEVENT
END:VCALENDAR